Institute of Cancer Research

Bladder cancer trial

Chemoradiotherapy lowers relapse risk

Childhood kidney cancer

Findings link gene variants to disease

Science Students

PhD studentships available

Clinical Trainees

Opportunities & support

Current Students

Available Supporting Resources

Staff Development

Training and Learning

Staff Benefits

Welfare and Facilities

Job Vacancies

Current vacancies

Legacies

Contribute to the future.

Student Bursary Programme

Opportunities

View our licensing portfolio

Successes

ICR’s enterprise achievements

Contacts

Get in touch with us

News

Drug developers welcome NICE guidance on abiraterone
[16 May 2012]
The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust have welcomed the publicatio...

New understanding of breast cancer genes and mutations
[16 May 2012]
Researchers have identified nine new genes that drive the development of breast cancer, taking the tally assoc...

Leading prostate cancer researchers elected to Academy of Medical Sciences
[10 May 2012]
Two eminent researchers from the ICR and The Royal Marsden have been elected to the Academy of Medical Science...

Next-generation “epigenetic” cancer pill shown to be safe
[01 May 2012]
Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is ...

Combining prostate cancer drugs could delay drug resistance, study finds
[01 May 2012]
Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length...

Scientists find DNA variants linked with childhood kidney cancer
[29 April 2012]
An international collaboration led by The Institute of Cancer Research (ICR) has found variations of the genet...

Existing drugs could treat smokers’ lung cancer
[26 April 2012]
A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressi...

Protein ‘block’ kills childhood cancer cells
[23 April 2012]
An experimental drug that blocks an essential cell protein could be used to treat Wilms tumour, a childhood ca...

Men with “breast cancer gene” four times more likely to get prostate cancer
[21 April 2012]
Men with a faulty gene known to increase the risk of breast cancer in women are four times more likely to deve...

Adding chemotherapy to radiotherapy halves risk of bladder cancer returning
[18 April 2012]
Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent les...